|
Originally published In Press as doi:10.1074/jbc.M011562200 on January 22, 2001
J. Biol. Chem., Vol. 276, Issue 17, 13718-13726, April 27, 2001
ATF-7, a Novel bZIP Protein, Interacts with the PRL-1
Protein-tyrosine Phosphatase*
Charles S.
Peters ,
Xianping
Liang ,
Shuixing
Li§,
Subburaj
Kannan§,
Yong
Peng ,
Rebecca
Taub , and
Robert H.
Diamond§¶
From the § Department of Medicine, Division of
Gastroenterology, and the Department of Genetics,
University of Pennsylvania School of Medicine, Philadelphia,
Pennsylvania 19104-6145
We have identified a novel basic leucine zipper
(bZIP) protein, designated ATF-7, that physically interacts with the
PRL-1 protein-tyrosine phosphatase (PTPase). PRL-1 is a predominantly nuclear, farnesylated PTPase that has been linked to the control of
cellular growth and differentiation. This interaction was initially found using the yeast two-hybrid system. ATF-7 is most closely related
to members of the ATF/CREB family of bZIP proteins, with highest
homology to ATF-4. ATF-7 homodimers can bind specifically to CRE
elements. ATF-7 is expressed in a number of different tissues and is
expressed in association with differentiation in the Caco-2 cell model
of intestinal differentiation. We have confirmed the PRL-1·ATF-7
interaction and mapped the regions of ATF-7 and PRL-1 important
for interaction to ATF-7's bZIP region and PRL-1's phosphatase domain. Finally, we have determined that PRL-1 is able to
dephosphorylate ATF-7 in vitro. Further insight into
ATF-7's precise cellular roles, transcriptional function, and
downstream targets are likely be of importance in understanding the
mechanisms underlying the complex processes of maintenance,
differentiation, and turnover of epithelial tissues.
*
This work is supported by National Institutes of Health
Grants R01 DK52216 and R01 DK44237, by University of Pennsylvania NIDDK/National Institutes of Health Center for Molecular Studies in
Digestive and Liver Diseases Grant P30 DK50306, and by the American
Digestive Health Foundation Miles and Shirley Fiterman Award for Basic
Science Research.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Medicine/GI Division, 664 Clinical Research Bldg., University of
Pennsylvania School of Medicine, 415 Curie Blvd., Philadelphia, PA
19104-6145. Tel.: 215-898-0155; Fax: 215-573-2024; E-mail:
diamondr@mail.med.upenn.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Li, W. Li, J. M. Angelastro, L. A. Greene, and D. X. Liu
Identification of a Novel DNA Binding Site and a Transcriptional Target for Activating Transcription Factor 5 in C6 Glioma and MCF-7 Breast Cancer Cells
Mol. Cancer Res.,
June 1, 2009;
7(6):
933 - 943.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. KNIPPEN, T. LONING, V. MULLER, C. SCHRODER, F. JANICKE, and K. MILDE-LANGOSCH
Expression and Prognostic Value of Activating Transcription Factor 2 (ATF2) and its Phosphorylated Form in Mammary Carcinomas
Anticancer Res,
January 1, 2009;
29(1):
183 - 189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pascual, M. J. Gomez-Lechon, J. V. Castell, and R. Jover
ATF5 Is a Highly Abundant Liver-Enriched Transcription Factor that Cooperates with Constitutive Androstane Receptor in the Transactivation of CYP2B6: Implications in Hepatic Stress Responses
Drug Metab. Dispos.,
June 1, 2008;
36(6):
1063 - 1072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Tommasino, M. Villani, A. Qureshi, J. Henry, C. Luberto, and M. Del Poeta
Atf2 Transcription Factor Binds to the APP1 Promoter in Cryptococcus neoformans: Stimulatory Effect of Diacylglycerol
Eukaryot. Cell,
February 1, 2008;
7(2):
294 - 301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tateyama, K. Horisawa, H. Takashima, E. Miyamoto-Sato, N. Doi, and H. Yanagawa
Affinity selection of DNA-binding protein complexes using mRNA display
Nucleic Acids Res.,
February 14, 2006;
34(3):
e27 - e27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Stephens, H. Han, V. Gokhale, and D. D. Von Hoff
PRL phosphatases as potential molecular targets in cancer
Mol. Cancer Ther.,
November 1, 2005;
4(11):
1653 - 1661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Forgacs, S. K. Gupta, J. A. Kerry, and O. J. Semmes
The bZIP Transcription Factor ATFx Binds Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax and Represses HTLV-1 Long Terminal Repeat-Mediated Transcription
J. Virol.,
June 1, 2005;
79(11):
6932 - 6939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Moorefield, S. J. Fry, and J. M. Horowitz
Sp2 DNA Binding Activity and trans-Activation Are Negatively Regulated in Mammalian Cells
J. Biol. Chem.,
April 2, 2004;
279(14):
13911 - 13924.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Angelastro, T. N. Ignatova, V. G. Kukekov, D. A. Steindler, G. B. Stengren, C. Mendelsohn, and L. A. Greene
Regulated Expression of ATF5 Is Required for the Progression of Neural Progenitor Cells to Neurons
J. Neurosci.,
June 1, 2003;
23(11):
4590 - 4600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Persengiev, L. R. Devireddy, and M. R. Green
Inhibition of apoptosis by ATFx: a novel role for a member of the ATF/CREB family of mammalian bZIP transcription factors
Genes & Dev.,
July 15, 2002;
16(14):
1806 - 1814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Si, Q. Zeng, C. H. Ng, W. Hong, and C. J. Pallen
Interaction of Farnesylated PRL-2, a Protein-tyrosine Phosphatase, with the beta -Subunit of Geranylgeranyltransferase II
J. Biol. Chem.,
August 24, 2001;
276(35):
32875 - 32882.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|